Forte Biosciences (FBRX) Operating Leases (2019 - 2020)
Forte Biosciences (FBRX) has disclosed Operating Leases for 2 consecutive years, with $3.9 million as the latest value for Q1 2020.
- Quarterly Operating Leases fell 59.07% to $3.9 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Mar 2020, down 59.07% year-over-year, with the annual reading at $4.0 million for FY2019, N/A changed from the prior year.
- Operating Leases for Q1 2020 was $3.9 million at Forte Biosciences, down from $4.0 million in the prior quarter.
- The five-year high for Operating Leases was $9.6 million in Q1 2019, with the low at $3.9 million in Q1 2020.